CINECA IRIS Institutional Research Information System

MARCOCCI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.735
EU - Europa 8.803
AS - Asia 2.926
AF - Africa 439
SA - Sud America 38
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 12
Totale 34.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.186
IT - Italia 2.856
SE - Svezia 2.037
CN - Cina 1.613
BG - Bulgaria 1.047
DE - Germania 703
CA - Canada 535
GB - Regno Unito 467
UA - Ucraina 431
VN - Vietnam 406
TR - Turchia 354
AT - Austria 340
FI - Finlandia 329
SG - Singapore 273
CI - Costa d'Avorio 270
CH - Svizzera 163
FR - Francia 146
RU - Federazione Russa 126
SN - Senegal 117
HK - Hong Kong 111
IN - India 99
BE - Belgio 44
NG - Nigeria 36
NL - Olanda 30
AU - Australia 16
KR - Corea 16
ES - Italia 13
EU - Europa 12
MX - Messico 12
BR - Brasile 10
PL - Polonia 10
RO - Romania 10
GR - Grecia 9
CO - Colombia 8
IR - Iran 6
JP - Giappone 6
PK - Pakistan 6
CL - Cile 5
DK - Danimarca 5
DZ - Algeria 5
EC - Ecuador 5
HU - Ungheria 5
ID - Indonesia 5
IE - Irlanda 5
IL - Israele 5
SA - Arabia Saudita 5
AR - Argentina 4
CZ - Repubblica Ceca 4
HR - Croazia 4
NO - Norvegia 4
MA - Marocco 3
NZ - Nuova Zelanda 3
PE - Perù 3
EE - Estonia 2
EG - Egitto 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CY - Cipro 1
GE - Georgia 1
IM - Isola di Man 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SD - Sudan 1
SM - San Marino 1
ZA - Sudafrica 1
Totale 34.972
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.498
Fairfield 2.760
Houston 2.090
Ann Arbor 2.058
Chandler 1.740
Ashburn 1.305
Seattle 1.153
Sofia 1.047
Wilmington 993
Cambridge 919
Milan 813
New York 668
Beijing 607
Jacksonville 544
Serra 509
Ottawa 508
Princeton 463
Lawrence 433
Medford 391
Vienna 309
Nanjing 289
Izmir 275
Abidjan 270
Des Moines 263
Dearborn 211
Dong Ket 205
Florence 194
Bern 155
San Diego 155
London 120
Nanchang 119
Dakar 115
Jüchen 113
Bremen 97
Hong Kong 94
Redwood City 83
Lancaster 80
Rome 77
Frankfurt am Main 73
Pisa 70
Kunming 68
Marseille 64
Boulder 63
Hebei 60
Shenyang 57
Norwalk 52
Changsha 50
Kocaeli 46
Düsseldorf 45
Hefei 45
Washington 44
Brussels 42
Tianjin 41
Ogden 40
Falls Church 38
Jiaxing 38
Los Angeles 38
Lagos 32
Kent 31
Guangzhou 26
Hangzhou 26
Pune 25
Vicopisano 25
Detroit 24
Auburn Hills 23
Chicago 22
Boardman 21
Jinan 21
Zhengzhou 19
Orange 18
Shanghai 17
Singapore 17
Ningbo 15
San Francisco 14
Verona 14
Grafing 13
Istanbul 13
Phoenix 13
Bergamo 12
Nürnberg 11
Renton 11
Chengdu 9
Hyderabad 9
San Jose 9
Toronto 9
Indiana 8
Kilburn 8
Redmond 8
Bogotá 7
Lanzhou 7
Livorno 7
Munich 7
Caldarola 6
Canterbury 6
Chongqing 6
Sacile 6
Aosta 5
Bari 5
Bexley 5
Central 5
Totale 27.292
Salva come PNG Salva come JPEG
Nome #
Complicanze chirurgiche in pazienti sottoposti a decompressione orbitaria per oftalmopatia di Graves [Surgical complications in orbital decompression for Graves’ orbitopathy] 358
Thyroid directed antibodies 246
Natural history of graves’ orbitopathy after treatment 165
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone 158
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I 156
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 155
Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency 152
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 148
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 146
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy 145
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial 144
1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth 143
Sortilin is a putative post-endocytic receptor of thyroglobulin 141
TSH-Dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells 140
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 140
Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women 139
A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1 139
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 139
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 137
More on smoking habits and Graves' ophthalmopathy 137
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 136
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 136
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 136
Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin 134
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 134
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST 133
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 133
Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cells 132
A proteomic approach to study parathyroid glands 132
Six novel MEN1 gene mutations in sporadic parathyroid tumors 132
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 130
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer 129
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves’ ophthalmopathy 129
Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited 128
Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells 127
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease 127
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 126
Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. 124
Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism 123
Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy 123
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation 122
null 121
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 121
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas 121
Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism 121
No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas 121
Primary hyperparathyroidism 121
Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells 120
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 120
THERAPEUTIC CONTROVERSIES. RADIOIODINE MAY BE BAD FOR GRAVES’ OPHTHALMOPATHY , BUT…… 119
Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? 119
Epidemiology, pathogenesis of primary hyperparathyroidism: Current data 119
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 118
Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia 118
Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism 118
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 118
Impaired Thyroglobulin (Tg) Secretion By FRTL-5 Cells Transfected With Soluble Receptor Associated Protein (RAP): Evidence For A Role Of RAP In The Tg Biosynthetic Pathway 116
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 116
Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy 115
a novel germline mutation of men 1 gene in a patient with acromegaly and multiple endocrine tumors 115
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO 115
Parafibromin as a tool for the diagnosis of parathyroid tumors 114
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 114
Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions 114
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? 114
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism 113
Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy 113
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 112
Orbital radiotherapy for Graves' ophthalmopathy 111
A treatment strategy for Graves' orbitopathy 111
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 111
Hereditary hypercalcemia caused by a homozygous pathogenic variant in the cyp24a1 gene: A case report and review of the literature 111
Parathyroid carcinoma 110
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 110
Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene 110
Demonstration and organ distribution of the 1,25-dihydroxyvitamin D3-binding protein in fish (A. anguilla) 109
Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses 109
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 109
Kidney abnormalities in low density lipoprotein receptor associated protein knockout mice 108
Microvessel density in human normal and neoplastic parathyroids 108
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis 108
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 108
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 108
A 2016 Italian Survey about the Clinical Use of Selenium in Thyroid Disease 107
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 107
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 107
Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why 106
DEFECTIVE THYROGLOBULIN (Tg) STORAGE IN LDL RECEPTOR ASSOCIATED PROTEIN (RAP) DEFICIENT MICE 106
Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations 106
The PRIMARA study: A prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice 106
Preoperative localization of suspicious parathyroid adenomas by assay of parathyroid hormone in needle aspirates 106
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 105
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 105
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement 105
Chirurgia dello strabismo nella oftalmopatia endocrina. 104
Thyroid volume and severity of graves' orbitopathy 104
Italian Society of Endocrinology Consensus Statement: Definition, evaluation and management of patients with mild primary hyperparathyroidism 104
Orbital irradiation in the treatment of Graves' ophthalmopathy 103
Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation 103
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 103
Totale 12.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.195
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.810 0 0 0 0 0 0 0 0 0 0 975 835
2019/20207.250 810 529 599 452 722 821 838 614 741 418 546 160
2020/20213.175 277 194 247 203 309 118 199 276 289 316 245 502
2021/20224.955 80 251 119 378 919 655 125 240 324 317 274 1.273
2022/20235.790 728 740 428 432 644 773 47 458 1.061 29 389 61
2023/20243.389 492 410 545 215 557 707 164 138 54 28 79 0
Totale 35.585